Barclays upgraded Iqvia (IQV) to Overweight from Equal Weight with an unchanged price target of $210. The firm sees upside to the stock’s valuation and and estimates. Iqvia’s history of execution should give the shares premium valuations versus the company’s late-stage peers, the analyst tells investors in a research note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV:
- Iqvia upgraded to Overweight from Equal Weight at Barclays
- MongoDB downgraded, Block upgraded: Wall Street’s top analyst calls
- Iqvia initiated with an Outperform at RBC Capital
- Iqvia to acquire certain discovery services assets from Charles River
- Iqvia price target lowered to $215 from $266 at Mizuho